Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Dicerna Pharmaceuticals Inc | d327055dex321.htm |
| EX-31.2 - EX-31.2 - Dicerna Pharmaceuticals Inc | d327055dex312.htm |
| EX-31.1 - EX-31.1 - Dicerna Pharmaceuticals Inc | d327055dex311.htm |
| 10-K - FORM 10-K - Dicerna Pharmaceuticals Inc | d327055d10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-202687 and 333-214082 on Form S-3 and in Registration Statement Nos. 333-193795 and 333-210071 on Form S-8 of our report dated March 30, 2017, relating to the consolidated financial statements of Dicerna Pharmaceuticals, Inc. and its subsidiaries appearing in this Annual Report on Form 10-K of Dicerna Pharmaceuticals, Inc. for the year ended December 31, 2016.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
March 30, 2017